Group 1 - Aehr Test Systems reported quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.03 per share, and down from $0.23 per share a year ago, representing an earnings surprise of -33.33% [1] - The company posted revenues of $13.45 million for the quarter ended November 2024, missing the Zacks Consensus Estimate by 7.86%, and down from $21.43 million year-over-year [2] - Over the last four quarters, the company has surpassed consensus EPS estimates three times, but has only topped consensus revenue estimates once [2] Group 2 - The stock has lost about 1.4% since the beginning of the year, compared to the S&P 500's decline of -0.9% [3] - The current consensus EPS estimate for the coming quarter is $0.08 on $20 million in revenues, and $0.31 on $70.9 million in revenues for the current fiscal year [7] - The Zacks Industry Rank for Electronics - Measuring Instruments is currently in the top 8% of over 250 Zacks industries, indicating a favorable outlook for the industry [8]

Financial Performance - Net revenue for Q2 fiscal 2025 was $13.5 million, a decrease of 37.5% from $21.4 million in Q2 fiscal 2024[7]. - GAAP net loss for Q2 fiscal 2025 was $(1.0) million, or $(0.03) per diluted share, compared to a net income of $6.1 million, or $0.20 per diluted share in Q2 fiscal 2024[7]. - Non-GAAP net income for Q2 fiscal 2025 was $0.7 million, or $0.02 per diluted share, down from $6.7 million, or $0.23 per diluted share in Q2 fiscal 2024[7]. - The company reported a net loss of $1.028 million for the quarter, compared to a net income of $660,000 in the previous quarter[27]. - Non-GAAP net income for the quarter was $691,000, compared to $2.153 million in the previous quarter, indicating a decline in profitability[30]. - The diluted net income per share was $(0.03), compared to $0.02 in the previous quarter, reflecting the company's financial challenges[30]. - Net income for the six months ended November 29, 2024, was a loss of $368,000, a significant decline from a profit of $10,763,000 in the same period last year[36]. Revenue and Bookings - Bookings for the quarter were $9.2 million, with a backlog of $12.4 million as of November 29, 2024[7]. - Total revenue for the second quarter of fiscal 2025 was $13.453 million, a 2.5% increase from $13.119 million in the previous quarter[26]. - Product revenue was $11.985 million, while service revenue was $1.468 million, indicating a strong performance in product sales[26]. - The company is reiterating its fiscal year 2025 revenue guidance of at least $70 million and a non-GAAP net profit before taxes of at least 10% of revenue[19]. Cash Flow and Liquidity - Total cash and cash equivalents as of November 29, 2024, was $35.2 million, down from $40.8 million as of August 30, 2024[7]. - Cash used in operating activities for the first six months of fiscal 2025 was $3.5 million[7]. - Cash and cash equivalents decreased to $32,217,000 from $49,159,000, reflecting a decline of approximately 34.4%[33]. - The company reported a net cash used in operating activities of $3,493,000 for the six months ended November 29, 2024, compared to cash provided of $3,356,000 in the prior year[36]. - The company incurred $10,615,000 in payments for business acquisition during the period, impacting cash flows from investing activities[36]. Expenses and Costs - Operating expenses totaled $6.913 million, slightly down from $6.919 million in the previous quarter, with R&D expenses at $2.276 million[27]. - Research and development expenses increased to $2.276 million, highlighting the company's commitment to innovation and new product development[27]. - Stock-based compensation expense rose to $1,945,000, up from $1,160,000, indicating an increase of approximately 67.4%[36]. Market and Product Insights - AI processors are projected to account for up to 40% of total revenue for the fiscal year, compared to effectively zero revenue last year[15]. - The gallium nitride (GaN) market is expected to exceed $2 billion in annual device sales by 2029, with a CAGR exceeding 40%[11]. - The acquisition of Incal Technology has accelerated market diversification, particularly in AI processors, contributing to new revenue opportunities[8]. - The company anticipates long-term demand for its products and aims to enter new markets, as indicated in its forward-looking statements[24]. - The company expects to generate bookings and revenue from its proprietary WaferPak and DiePak consumables in emerging markets[24]. Balance Sheet Highlights - Total assets increased to $142,280,000 as of November 29, 2024, up from $127,912,000 on May 31, 2024, representing a growth of approximately 11%[33]. - Current liabilities rose to $11,717,000, compared to $10,508,000 in the previous period, indicating an increase of about 11.5%[34]. - Total shareholders' equity increased to $123,181,000 from $111,593,000, marking an increase of about 10.4%[34]. - Accounts receivable decreased by $3,718,000, compared to a decrease of $12,037,000 in the previous year, showing a significant change in collection efficiency[36]. - The company reported a total of 29,709,000 shares issued and outstanding as of November 29, 2024, compared to 28,995,000 shares in the previous period[34].

Revenue Performance - Revenue decreased to $26.6 million for the six months ended November 29, 2024 from $42.1 million for the six months ended November 30, 2023, driven by a decline in power semiconductor demand for electric vehicles[110] - Asia revenue decreased by 48% to $9.83 million for the three months ended November 29, 2024 compared to $18.92 million for the same period in 2023[111] - United States revenue increased by 412% to $3.46 million for the three months ended November 29, 2024 compared to $0.68 million for the same period in 2023, driven by contributions from Incal customers[111] - Asia region net revenues for Q3 2024 were $9.825 million, a 48.1% decrease from $18.922 million in Q3 2023[76] - United States net revenues for Q3 2024 were $3.462 million, a 412.1% increase from $676 thousand in Q3 2023[76] - Europe net revenues for Q3 2024 were $166 thousand, a 90.9% decrease from $1.833 million in Q3 2023[76] - Systems product category net revenues for Q3 2024 were $3.410 million, a 68.1% decrease from $10.685 million in Q3 2023[76] - Contactors product category net revenues for Q3 2024 were $8.575 million, a 6.3% decrease from $9.152 million in Q3 2023[76] - Services net revenues for Q3 2024 were $1.468 million, a 7.9% decrease from $1.594 million in Q3 2023[76] - Total net revenues for Q3 2024 were $13.453 million, a 37.2% decrease from $21.431 million in Q3 2023[76] - Asia region net revenues for H1 2024 were $22.403 million, a 41.3% decrease from $38.153 million in H1 2023[76] - United States net revenues for H1 2024 were $3.984 million, a 172.0% increase from $1.465 million in H1 2023[76] - Europe net revenues for H1 2024 were $185 thousand, a 92.4% decrease from $2.437 million in H1 2023[76] Gross Profit and Margin - Gross profit decreased by 51% to $5.4 million for the three months ended November 29, 2024 compared to $10.96 million for the same period in 2023[112] - Gross margin decreased to 40.1% for the three months ended November 29, 2024 from 51.1% for the same period in 2023[112] Cash and Investments - Cash, cash equivalents, and restricted cash decreased to $35.2 million as of November 29, 2024 from $50.7 million as of November 30, 2023[121] - Net cash used in investing activities increased by $28.7 million for the six months ended November 29, 2024 compared to the same period in 2023, primarily due to the $10.6 million acquisition of Incal[125] Tax and Financial Impact - The company recognized an income tax benefit due to quarter-to-date and year-to-date losses in the U.S. for the three and six months ended November 29, 2024[120] Geopolitical Risks - Geopolitical tensions between the United States and China could create barriers to selling products and services in China, potentially impacting the company's growth prospects and financial condition[133] Systems Revenue - The company's systems revenue decreased by $15.3 million for the six months ended November 29, 2024 compared to the same period in 2023, partially offset by a $5.0 million increase in package parts burn-in systems revenue from the Incal acquisition[110]

Class Action Notice - The Gross Law Firm is issuing a notice to shareholders of Aehr Test Systems, Inc (NASDAQ: AEHR) who purchased shares during the class period from January 9, 2024, to March 24, 2024 [1] - Shareholders are encouraged to contact the firm regarding possible lead plaintiff appointment, with no obligation to partake in any recovery [1] - The deadline for shareholders to register for this class action is February 3, 2025 [2] Allegations - The complaint alleges that during the class period, Aehr Test Systems issued materially false and/or misleading statements and/or failed to disclose substantial delays in customer orders [1] - These delays were likely to have a material negative impact on the company's revenue growth, leading to overstated business and financial prospects [1] - As a result, the company's public statements were materially false and misleading at all relevant times [1] Next Steps for Shareholders - Shareholders who register will be enrolled in a portfolio monitoring software to receive status updates throughout the lifecycle of the case [2] - There is no cost or obligation for shareholders to participate in this case [2] About The Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investor rights against deceit, fraud, and illegal business practices [3] - The firm seeks recovery on behalf of investors who incurred losses due to false and/or misleading statements or omissions of material information by companies [3]

LOS ANGELES, Jan. 10, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Aehr Test Systems, Inc. ("Aehr" or the "Company") (NASDAQ: AEHR).IF YOU SUFFERED A LOSS ON YOUR AEHR INVESTMENTS, CLICK HERE BEFORE FEBRUARY 3, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About? The complaint filed alleges that, between January 9, 2024 and March 24, 2024, De ...

NEW YORK, Jan. 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Aehr Test Systems, Inc. ("Aehr" or the "Company") (NASDAQ: AEHR) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Aehr investors who were adversely affected by alleged securities fraud between January 9, 2024 and March 24, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/aehr-lawsuit-submission-form?prid ...

NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aehr Test Systems (NASDAQ: AEHR) between January 9, 2024 and March 24, 2024, both dates inclusive (the “Class Period”), of the important February 3, 2025 lead plaintiff deadline. SO WHAT: If you purchased Aehr securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT ...

NEW YORK, Jan. 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Aehr Test Systems, Inc. (NASDAQ: AEHR).Shareholders who purchased shares of AEHR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/aehr-loss-submission-form/?id=121476&from=4CLASS PERIOD: January 9, 2024 to March ...

Shares of Aehr Test Systems (AEHR 8.72%) rallied today, rising 9.3% as of 11:52 a.m. ET, defying the broader tech market, which was down significantly.Aehr announced its first-ever order for gallium nitride (GaN) chips today. This order represents an expansion of Aehr's addressable market, which management had predicted. That in turn lends credibility to Aehr's management and thus optimism for the company's future.A gallium nitride winThis morning, Aehr put out a press release saying it had secured an order ...

Core Viewpoint - A class action securities lawsuit has been filed against Aehr Test Systems, Inc. for alleged securities fraud affecting investors between January 9, 2024, and March 24, 2024 [1][2] Group 1: Allegations and Impact - The lawsuit claims that Aehr made false statements and concealed significant delays in customer orders, which were contrary to prior representations [2] - These delays are expected to have a material negative impact on the Company's revenue growth, leading to overstated business and financial prospects [2] - As a result, the Company's public statements were deemed materially false and misleading throughout the relevant period [2] Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until February 3, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3] - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees, with no obligation to participate [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4] - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4]